LONDON, December 16th, 2021 – Materia today announces that its wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta” or “the “Company”) has commenced sales of the first medical cannabis flower produced at its EU GMP certified manufacturing site.
Read moreMateria Receives Commercial Production Licence for Malta Facility
LONDON, September 14th, 2021 — Materia today announces that its wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta” or the “Company”) has received its Licence for the Production of Cannabis for Medicinal and Research Purposes (the “Licence”) from the Malta Medicines Authority.
Read moreMateria Announces Receipt of EU-GMP Certification in Malta
LONDON, May 13, 2021 — Materia, a medical cannabis and wellness company focused on the European market, today announces that its wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta” or the “Company”) has received its European Union Good Manufacturing Practices (“EU GMP”) certification from the Malta Medicines Authority.
Read more